Jim Jogerst

Chief Business Officer at Rubius Therapeutics - Cambridge, Massachusetts, US

Jim Jogerst's Colleagues at Rubius Therapeutics
Lili Wang

Associate Director, Analytical Development

Contact Lili Wang

Jill Murray

Director, HR Business Partner & Interim Head of Total Rewards

Contact Jill Murray

Brenda Hugh

Associate Director Supply Chain, Sourcing

Contact Brenda Hugh

Charles Simmons

Senior Manager Quality Assurance Operations

Contact Charles Simmons

View All Jim Jogerst's Colleagues
Jim Jogerst's Contact Details
HQ
(617) 679-9600
Location
Cambridge, Massachusetts, United States
Company
Rubius Therapeutics
Jim Jogerst's Company Details

Rubius Therapeutics

Cambridge, Massachusetts, US • 250 - 499 Employees
BioTech/Drugs

Rubius Therapeutics is a biopharmaceutical company pioneering a new era of cellular medicines. Our proprietary RED PLATFORM™ was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and ready to-use cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Our initial focus is to advance RCT™ product candidates for the treatment cancer and autoimmune diseases by leveraging two distinct therapeutic modalities — potent cell-cell interaction and tolerance induction. We are currently enrolling patients in a Phase 1/2 clinical trial of RTX-240; the trial has two Phase 1 arms enrolling adult patients with advanced solid tumors: an ongoing monotherapy dose escalation arm in adults with relapsed/refractory or locally advanced solid tumors and a combination therapy dose escalation arm with pembrolizumab in adults with relapsed/refractory or locally advanced solid tumors. In April 2022, the combination arm with pembrolizumab was expanded to focus on non-small cell lung cancer and renal cell carcinoma patients. We are also enrolling patients in a Phase 1/2 clinical trial of RTX-224 for the treatment of patients with certain advanced solid tumors, including non-small cell lung cancer, cutaneous melanoma, head and neck squamous cell carcinoma, urothelial (bladder) carcinoma and triple-negative breast cancer.

Rubius Therapeutics Rubius Red Platform Rubius Rubius Therapeutics Pitch Deck Rubius Thera
Details about Rubius Therapeutics
Frequently Asked Questions about Jim Jogerst
Jim Jogerst currently works for Rubius Therapeutics.
Jim Jogerst's role at Rubius Therapeutics is Chief Business Officer.
Jim Jogerst's email address is ***@rubiustx.com. To view Jim Jogerst's full email address, please signup to ConnectPlex.
Jim Jogerst works in the BioTech/Drugs industry.
Jim Jogerst's colleagues at Rubius Therapeutics are Lili Wang, Maegan Hoover, Pavan Puligujja, Jill Murray, Brenda Hugh, Lindsey Gardell, Charles Simmons and others.
Jim Jogerst's phone number is (617) 679-9600
See more information about Jim Jogerst